| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.52 | 0.07 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |